Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

RBC Capital analyst Brian Abrahams maintained a Hold rating on 89bio (ETNB – Research Report) yesterday and set a price target of $12.00.

In a report released today, Michael Yee from Jefferies maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a ...

The Nursing Beat, the leading daily digital newsletter designed for nurses by nurses, today announced the first close of an equity funding round. This milestone investment underscores the growing ...

The drug, which continues to be available for certain breast cancer patients and is being tested in other cancers, was the central part of Gilead's $21 billion acquisition of Immunomedics four ...

At the Bay Area Council’s annual Hall of Fame dinner in San Francisco ... firm Francisco Partners. Robertson advised many of Silicon Valley’s best known companies, including Gilead Sciences ...

Prospects for Gilead Sciences' Trodelvy in hormone receptor ... of the University of California San Francisco Comprehensive Cancer Centre. "Nearly all patients with HR+/HER2- metastatic breast ...

Breckenridge spirits have been awarded 6 Double Golds at the San Francisco World Spirits Competition ... access to their most valuable assets when making both current... Gilead Sciences, Inc. today ...

California is home base to the largest young companies, such as OpenAI and Anthropic in San Francisco ... former CFO of Gilead Sciences, to its board. Both new members also serve on the boards ...

On September 30th, 1996, Roche entered into a collaboration agreement with Gilead Sciences ... Nutley was moved to Genentech’s facility in San Francisco. Genentech strengthens Roche’s access ...